Literature DB >> 178403

Editorial: Ectopic secretion by tumours.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178403      PMCID: PMC1640293     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  15 in total

1.  BRONCHOGENIC CARCINOMA WITH INAPPROPRIATE ANTIDIURETIC ACTIVITY IN PLASMA AND TUMOR.

Authors:  B F BOWER; D M MASON; P H FORSHAM
Journal:  N Engl J Med       Date:  1964-10-29       Impact factor: 91.245

2.  INAPPROPRIATE SECRETION OF VASOPRESSIN.

Authors:  J LEE; J J JONES; M A BARRACLOUGH
Journal:  Lancet       Date:  1964-10-10       Impact factor: 79.321

Review 3.  The biosynthesis of hormones by non-endocrine tumours--a review.

Authors:  L H Rees
Journal:  J Endocrinol       Date:  1975-10       Impact factor: 4.286

4.  Paraneoplastic syndromes. Hyperadrenocorticism and ACTH-releasing factor.

Authors:  T T Amatruda; G V Upton
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

5.  Differences between ectopic MSH and pituitary MSH.

Authors:  M Shapiro; W E Nicholson; D N Orth; W M Mitchell; G W Liddle
Journal:  J Clin Endocrinol Metab       Date:  1971-09       Impact factor: 5.958

6.  Radioimmunoassay and saturation analysis. Tumor-associated antigens.

Authors:  K D Bagshawe
Journal:  Br Med Bull       Date:  1974-01       Impact factor: 4.291

7.  Differences between purified ectopic and normal alpha subnits of human glycoprotein hormones.

Authors:  B D Weintraub; G Krauth; S W Rosen; A S Babson
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

8.  Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.

Authors:  H W Seyberth; G V Segre; J L Morgan; B J Sweetman; J T Potts; J A Oates
Journal:  N Engl J Med       Date:  1975-12-18       Impact factor: 91.245

9.  Ectopic ACTH production in carcinoma of the lung.

Authors:  G Gewirtz; R S Yalow
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

10.  Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.

Authors:  A H Tashjian; E F Voelkel; L Levine; P Goldhaber
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.